HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Austin Poole Selected Research

Austin Poole Research Topics

Disease

3Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 06/2015
3Neoplasms (Cancer)
01/2020 - 01/2015
3Prostatic Neoplasms (Prostate Cancer)
01/2019 - 09/2017
3Carcinoma (Carcinomatosis)
01/2017 - 09/2014
1Mucositis
04/2018
1Fatigue
04/2018
1Hand-Foot Syndrome
04/2018
1Non-Muscle Invasive Bladder Neoplasms
01/2017
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2017
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2017
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017
1Hypothyroidism
06/2015
1Neoplasm Metastasis (Metastasis)
04/2015
1Leukocytosis (Pleocytosis)
04/2015
1Anemia
04/2015
1Cytopenia
09/2014

Drug/Important Bio-Agent (IBA)

2Prednisone (Sone)FDA LinkGeneric
01/2019 - 01/2018
2Abiraterone AcetateIBA
01/2019 - 01/2018
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2018 - 06/2015
2Tyrosine Kinase InhibitorsIBA
04/2018 - 06/2015
2Cisplatin (Platino)FDA LinkGeneric
04/2015 - 09/2014
1pazopanibFDA Link
01/2020
1SaltsIBA
01/2019
1Ketoconazole (Nizoral)FDA LinkGeneric
01/2018
1AndrogensIBA
01/2018
1Androgen Antagonists (Antiandrogens)IBA
09/2017
1enzalutamideIBA
09/2017
1PlatinumIBA
01/2017
1atezolizumabIBA
01/2017
1ibrutinibIBA
01/2017
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
06/2015
1AlbuminsIBA
04/2015
1Biomarkers (Surrogate Marker)IBA
01/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015
1GemcitabineFDA Link
09/2014
1Lenalidomide (CC 5013)FDA Link
09/2014

Therapy/Procedure

4Therapeutics
01/2018 - 09/2014
3Castration
01/2019 - 09/2017
2Immunotherapy
01/2020 - 01/2017
2Drug Tapering
04/2018 - 06/2015
2Drug Therapy (Chemotherapy)
01/2017 - 09/2014
1Radiotherapy
01/2017